News & Insights

The private M&A market witnessed a record quarter for deal volumes in Q1 2022, reaching just shy of 600 deals. This was delivered on the back of continued adoption of cloud technologies, increased investment into hybrid work environments and software vendors seeking to deepen their security posture. CG Results advised AI-powered brand language optimisation platform […]

Despite a backdrop of some macroeconomic uncertainty, private M&A activity within the global technology market saw a record quarter for deal volumes. This was delivered on the back of continued adoption of cloud technologies, increased focus on strategic tuck-ins, investment into hybrid work environments and software vendors seeking to deepen their security posture. As public […]

In February of 2021, Sideshow, an independent digital group, partnered with Waterland Private Equity to support its ambitious growth plans to continue building a group of highly connected digital brands. One year on we caught up with Sideshow’s Tony Hill, Founder and CEO, and Dominic Graham, Investment Director at Waterland to discuss the journey to […]

For the first time in forever it felt like the good old days were back in midtown Manhattan at everyone’s favourite pharma supply chain conference The hotels. The meetings. The dinners. Walking up and down Lexington Avenue and bumping into friends and colleagues. It was all happening again at DCAT last week in New York. […]

The Russian invasion of Ukraine has been touted as the final nail in the coffin of globalisation, confirming the nationalisation of key industries and products. With respect to pharmaceutical manufacturing, this is accelerating a trend which has been ongoing for 10 years, the repatriation of drug manufacturing from Asia to the US and Europe has […]

M&A appetite for MSPs continues to surge with broad buyer interest across the ecosystem, meaning that if your MSP is showing the right characteristics there will be lots of options to realise value. So what does good look like and who will be interested? Click to read Managed Service Providers – What are the right […]

We are pleased to share with you the FY 2021 Marketing Services Sector Review, where we analyse global M&A activity and public market performance in the marketing services sector. The M&A market for Marketing Services remains dynamic with 2021 deal volume up by over 25% on 2020 levels at 756 versus 602 total deals respectively. […]

Whilst the pandemic has caused unprecedented disruption on research and clinical trials, it has also launched the clinical trial landscape into a new area, one with the enhanced utilisation of decentralised trials and the long-awaited embracement of digital technologies to deliver improved patient care, reduced clinical trial costs and speedier outcomes. We have also seen […]

Discovery Contract Research Organisations (“CROs”) essentially provide lab-based discovery services such as medicinal chemistry, biological screening etc to pharma companies and biotech, and this business segment has exploded in size, sophistication and value in recent years and is now a focus of both M&A and PE investment. This is covered in our forthcoming white paper […]